Peter Wang
Impact in
-
- Cancer-related molecular mechanisms research
-
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- Protein Degradation and Inhibitors
- Cancer-related gene regulation
- Histone Deacetylase Inhibitors Research
Papers in
-
- Ubiquitin and proteasome pathways 8
- Circular RNAs in diseases 4
- Glycosylation and Glycoproteins Research 3
- Protein Degradation and Inhibitors 3
- Cancer-related gene regulation 3
- Epigenetics and DNA Methylation 3
-
- Cancer-related molecular mechanisms research 6
- Co-authors
- Wenjun Liu (6 shared papers)Guanning Shang (3 shared papers)Wenxiao Jiang (1 shared paper)Yuyun Li (1 shared paper)Wenyi Wei (1 shared paper)Xiaoming Dai (1 shared paper)Ting Chen (2 shared papers)Qiuli Chen (4 shared papers)
- Journals
- Frontiers in Oncology (3 papers)Seminars in Cancer Biology (3 papers)Annals of Oncology (3 papers)Frontiers in Immunology (3 papers)Aging (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Peter Wang
27 papers receiving 417 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 89
- Molecular Biology 289
- Oncology 102
- Immunology 46
- Cell Biology 34
Countries citing papers authored by Peter Wang
This map shows the geographic impact of Peter Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Wang more than expected).
Fields of papers citing papers by Peter Wang
This network shows the impact of papers produced by Peter Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Wang. The network helps show where Peter Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 76 | |
| 2 | 2022 | 47 | |
| 3 | 2014 | 45 | |
| 4 | 2022 | 39 | |
| 5 | 2023 | 33 | |
| 6 | 2022 | 33 | |
| 7 | 2022 | 22 | |
| 8 | 2009 | 20 | |
| 9 | 2022 | 14 | |
| 10 | 2022 | 14 | |
| 11 | 2023 | 13 | |
| 12 | 2020 | 12 | |
| 13 | 2022 | 9 | |
| 14 | 2018 | 8 | |
| 15 | 2024 | 7 | |
| 16 | 2023 | 7 | |
| 17 | 2023 | 5 | |
| 18 | 2022 | 4 | |
| 19 | 2023 | 4 | |
| 20 | 2024 | 3 |
About Peter Wang
Peter Wang is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Surgery, having authored 29 papers that have together received 423 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (8 papers), Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (4 papers), Glycosylation and Glycoproteins Research (3 papers), Protein Degradation and Inhibitors (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer-related gene regulation (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Cancer Research (89 citations), Molecular Biology (289 citations), Oncology (102 citations), Immunology (46 citations) and Cell Biology (34 citations). Peter Wang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Wenjun Liu, Guanning Shang, Wenxiao Jiang, Yuyun Li, Wenyi Wei, Xiaoming Dai, Ting Chen, Qiuli Chen, Shizhe Li and Jinxin Liu. Their work appears in journals such as Frontiers in Oncology, Seminars in Cancer Biology, Annals of Oncology, Frontiers in Immunology and Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.